Skip to content

Pelvic-Restricted vs. Pelvic-Free Robot-Assisted Gait Training in Stroke Patients

Comparison of Pelvic-Free and Pelvic-Restricted Robot-Assisted Gait Training on Walking Pattern, Balance, and Fear of Falling After Stroke

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07365384
Enrollment
36
Registered
2026-01-26
Start date
2026-01-15
Completion date
2026-04-01
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance Impairment, Fear of Falling, Gait Disorder, Sensorimotor, Hemiplegia, Stroke

Brief summary

This randomized controlled clinical trial aims to compare the effects of pelvic-free versus pelvic-restricted robot-assisted gait training (RAGT) on gait pattern, balance, and fear of falling in stroke patients. Stroke survivors often experience gait impairments, reduced balance, and fear of falling, which limit independence and quality of life. Conventional physiotherapy requires high intensity and repetition but is restricted by therapist capacity. Robotic gait systems provide intensive, repetitive, and safe training; however, most limit pelvic motion, potentially disrupting natural gait patterns and balance strategies. A total of 36 participants with chronic stroke (≥6 months post-stroke, age ≥18 years, hemiplegic gait disorder, Functional Ambulation Category ≥2) will be randomized into two groups: (1) pelvic-free RAGT plus conventional rehabilitation, or (2) pelvic-restricted RAGT plus conventional rehabilitation. Interventions will consist of 8 RAGT sessions (twice weekly) and 20 conventional rehabilitation sessions (five times weekly) over 4 weeks. Primary outcomes include gait analysis parameters (gait speed, step length, cadence, temporal symmetry index) and clinical measures such as the Berg Balance Scale, Functional Ambulation Category, Motricity Index (lower limb), and Falls Efficacy Scale-International. Assessments will be performed at baseline and after 4 weeks of treatment. The study hypothesizes that pelvic-free RAGT will improve gait symmetry, balance, and reduce fear of falling more effectively than pelvic-restricted training. Results are expected to provide evidence supporting the integration of pelvic-free robotic gait systems into post-stroke rehabilitation to enhance functional recovery and patient confidence

Interventions

DEVICERoboGait® Pelvic-Free Mode

Robot-assisted gait training using the RoboGait® system in pelvic-free mode. Participants receive 8 sessions (2 per week for 4 weeks) in addition to conventional rehabilitation.

DEVICERoboGait® Pelvic-Restricted Mode

Robot-assisted gait training using the RoboGait® system in pelvic-restricted mode. Participants receive 8 sessions (2 per week for 4 weeks) in addition to conventional rehabilitation.

OTHERConventional Rehabilitation

Standard physiotherapy program consisting of 20 sessions (5 per week for 4 weeks) focused on mobility, strengthening, and functional training. Applied to all participants in both groups.

Sponsors

Meltem Gunes Akinci
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * History of stroke more than 6 months prior * Presence of hemiplegia-related gait disorder * Functional Ambulation Category (FAC) score ≥ 2 * Ability to walk independently prior to stroke

Exclusion criteria

* Severe cognitive or communication impairment * Movement limitations due to joint contracture or deformity * Presence of open wounds or pressure ulcers * Uncontrolled hypertension or orthostatic hypotension * Severe cardiovascular disease, heart failure, cancer, or serious pulmonary disease * High risk of fracture due to severe osteoporosis * Gait impairment caused by lower extremity musculoskeletal disorders * Severe psychosis/neurosis * Modified Ashworth Scale \> 3 in the lower extremities (severe spasticity)

Design outcomes

Primary

MeasureTime frameDescription
Berg Balance ScaleBaseline (T0) and 4 weeks post-intervention (T1)14-item scale assessing static and dynamic balance, scored 0-56 (higher scores indicate better balance).
Gait SpeedBaseline (T0) and 4 weeks post-intervention (T1)Gait speed will be assessed using the Zebris FDM-T treadmill system and expressed in meters per second (m/s).
Step LengthBaseline (T0) and 4 weeks post-intervention (T1)Step length will be measured with the Zebris FDM-T treadmill system and reported in centimeters (cm).
CadenceBaseline (T0) and 4 weeks post-intervention (T1)Cadence will be recorded using the Zebris FDM-T treadmill system and expressed in steps per minute.
Double Support TimeBaseline (T0) and 4 weeks post-intervention (T1)Double support time will be assessed with the Zebris FDM-T treadmill system and expressed as percentage (%) of the gait cycle.
Temporal Symmetry IndexBaseline (T0) and 4 weeks post-intervention (T1)Temporal symmetry index will be calculated from gait analysis with the Zebris FDM-T treadmill system and expressed as a percentage (%).

Secondary

MeasureTime frameDescription
Functional Ambulation Category (FAC)Baseline (T0) and 4 weeks post-intervention (T1)6-level scale (0-5) evaluating functional walking ability, from non-functional ambulation to independent walking.
Motricity Index - Lower LimbBaseline (T0) and 4 weeks post-intervention (T1)Assesses motor function of the paretic lower limb (score range 0-99)
Falls Efficacy Scale-International (FES-I)Baseline (T0) and 4 weeks post-intervention (T1)Self-reported questionnaire evaluating fear of falling during daily activities (higher scores indicate greater fear).

Contacts

CONTACTMeltem Güneş Akıncı, MD
mgakinci@pau.edu.tr+902582966000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026